Company Valuation: enGene Therapeutics Inc.

Data adjusted to current consolidation scope
Fiscal Period: October 2023 2024 2025 2026 2027 2028
Market Cap 1 - 451.1 369.1 115.3 - -
Change - - -18.18% -68.77% - -
Enterprise Value (EV) 1 - 236 190.7 -69.25 40.8 -25.35
Change - - -19.19% -136.32% 158.92% -162.13%
P/E -0.14x -6.06x -3.15x -0.93x -1.08x -1.64x
PBR - 1.65x 2.2x 0.63x 1.56x 1.11x
PEG - 0.1x -0.1x 0x 0.1x 0x
Capitalization / Revenue - - - - 24.6x 2.94x
EV / Revenue - - - - 8.72x -0.65x
EV / EBITDA - -3.81x -1.55x 0.57x -0.34x 0.2x
EV / EBIT - -3.79x -1.55x 0.54x -0.34x 0.25x
EV / FCF - - -1.89x 0.5x -0.26x 0.18x
FCF Yield - - -52.8% 200% -382% 555%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -151.2 -1.46 -2.29 -1.84 -1.597 -1.051
Distribution rate - - - - - -
Net sales 1 - - - - 4.678 39.19
EBITDA 1 - -61.97 -122.7 -121.4 -121.3 -125.7
EBIT 1 - -62.3 -123.2 -128 -118.6 -100.7
Net income 1 -99.92 -55.14 -117.3 -125.2 -118.2 -102.6
Net Debt 1 - -215.2 -178.4 -184.5 -74.46 -140.6
Reference price 2 21.695 8.850 7.210 1.720 1.720 1.720
Nbr of stocks (in thousands) - 50,974 51,192 67,016 - -
Announcement Date 29/01/24 19/12/24 22/12/25 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-0.93x - 0.57x-.--% 115M
17.32x6.64x12.72x1.72% 66.37B
31.83x8.5x28.08x0.07% 58.86B
38.41x6.84x20.46x0.85% 55.22B
44.35x6.2x29.52x-.--% 47.21B
33.62x3.22x13.9x-.--% 42.45B
35.98x8.9x23.21x0.36% 36.44B
-19.28x55.7x-21.11x-.--% 35.19B
41.59x8.02x26.91x-.--% 32.66B
-74.36x14.09x-75.73x-.--% 26.73B
Average 14.85x 13.12x 5.85x 0.3% 40B
Weighted average by Cap. 21.60x 11.64x 11.38x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - enGene Therapeutics Inc.

Historical PBR trend

Valuation ratios - PBR - enGene Therapeutics Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - enGene Therapeutics Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - enGene Therapeutics Inc.


Year-on-year evolution of the Yield

Valuation ratios - Yield - enGene Therapeutics Inc.
  1. Stock Market
  2. Stocks
  3. ENGN Stock
  4. Valuation enGene Therapeutics Inc.